Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.45 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DUT | P33316 | 9/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572752 | 0.75 | CRBN (0.54) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL5705360 | 0.73 | CRBN (0.47) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL7743211 | 0.72 | CRBN (0.50) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL7614894 | 0.71 | PKM (0.51) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL3472507 | 0.69 | CRBN (0.47) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL1433847 | 0.69 | ENPP1 (0.46) | CRBNDDB1ALDH1A1LMNA | |
| SCHEMBL5583926 | 0.69 | CRBN (0.42) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL2119230 | 0.67 | ALDH1A1 (0.44) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL4409228 | 0.67 | ALDH1A1 (0.41) | CRBNDDB1PKML3MBTL1ALDH1A1 | |
| SCHEMBL11618549 | 0.67 | CRBN (0.44) | CRBNDDB1PKML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8598088-B2 | Methods for simplifying microbial nucleic acids by chemical modification of cytosines | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2013-12-03 | — | — | US | disclosed |
| US-8431347-B2 | Isothermal strand displacement amplification using primers containing a non-regular base | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2013-04-30 | — | — | US | disclosed |
| US-8343738-B2 | Assay for screening for potential cervical cancer | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2013-01-01 | — | — | US | disclosed |
| EP-1828411-B1 | METHODS FOR SIMPLIFYING MICROBIAL NUCLEIC ACIDS BY CHEMICAL MODIFICATION OF CYTOSINES | HUMAN GENETIC SIGNATURES PTY (AU) | 2012-11-07 | — | — | EP | disclosed |
| US-20120021461-A1 | ISOTHERMAL STRAND DISPLACEMENT AMPLIFICATION | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2012-01-26 | — | — | US | disclosed |
| EP-1943353-B1 | ASSAY FOR A HEALTH STATE | HUMAN GENETIC SIGNATURES PTY (AU) | 2011-11-02 | — | — | EP | disclosed |
| EP-2379719-A1 | IMPROVED ISOTHERMAL STRAND DISPLACEMENT AMPLIFICATION | Human Genetic Signatures Pty Ltd (AU) | 2011-10-26 | — | — | EP | disclosed |
| US-20110136098-A1 | METHODS FOR SIMPLIFYING MICROBIAL NUCLEIC ACIDS BY CHEMICAL MODIFICATION OF CYTOSINES | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2011-06-09 | — | — | US | disclosed |
| US-7846693-B2 | Nucleic acid detection assay | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2010-12-07 | — | — | US | disclosed |
| US-7833942-B2 | Methods for simplifying microbial nucleic acids by chemical modification of cytosines | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2010-11-16 | — | — | US | disclosed |
| WO-2006066353-A1 | DETECTION OF HUMAN PAPILLOMA VIRUS | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2006-06-29 | — | — | WO | disclosed |
| EP-1668148-A1 | NUCLEIC ACID DETECTION ASSAY | Human Genetic Signatures PTY Ltd. (AU) | 2006-06-14 | — | — | EP | disclosed |
| WO-2006058393-A1 | METHODS FOR SIMPLIFYING MICROBIAL NUCLEIC ACIDS BY CHEMICAL MODIFICATION OF CYTOSINES | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2006-06-08 | — | — | WO | disclosed |
| EP-1641936-A1 | METHODS FOR GENOME AMPLIFICATION | Human Genetic Signatures PTY Ltd. (AU) | 2006-04-05 | — | — | EP | disclosed |
| WO-2006026828-A1 | AMPLIFICATION BLOCKER COMPRISING INTERCALATING NUCLEIC ACIDS (TNA) CONTAINING INTERCALATING PSEUDONUCLEOTIDES (IPN) | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2006-03-16 | — | — | WO | disclosed |
| EP-1592807-A1 | ASSAY FOR DETECTING METHYLATION CHANGES IN NUCLEIC ACIDS USING AN INTERCALATING NUCLEIC ACID | Human Genetic Signatures PTY Ltd. (AU) | 2005-11-09 | — | — | EP | disclosed |
| WO-2005024053-A1 | NUCLEIC ACID DETECTION ASSAY | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2005-03-17 | — | — | WO | disclosed |
| WO-2004111229-A1 | METHYLOMIC ANALYSIS-CYTOSINE CELLULAR SIGNATURES | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004111266-A1 | METHODS FOR GENOME AMPLIFICATION | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004065625-A1 | ASSAY FOR DETECTING METHYLATION CHANGES IN NUCLEIC ACIDS USING AN INTERCALATING NUCLEIC ACID | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2004-08-05 | — | — | WO | disclosed |